See more : Horace Mann Educators Corporation (HMN) Income Statement Analysis – Financial Results
Complete financial analysis of DENTSPLY SIRONA Inc. (XRAY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DENTSPLY SIRONA Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Envirotech Vehicles, Inc. (ADOM) Income Statement Analysis – Financial Results
- Yijiahe Technology Co., Ltd. (603666.SS) Income Statement Analysis – Financial Results
- CITIC Guoan Information Industry Co., Ltd. (000839.SZ) Income Statement Analysis – Financial Results
- Ocugen, Inc. (OCGN) Income Statement Analysis – Financial Results
- Nanobac Pharmaceuticals, Incorporated (NNBP) Income Statement Analysis – Financial Results
DENTSPLY SIRONA Inc. (XRAY)
About DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.97B | 3.92B | 4.25B | 3.34B | 4.03B | 3.99B | 3.99B | 3.75B | 2.67B | 2.92B | 2.95B | 2.93B | 2.54B | 2.22B | 2.16B | 2.19B | 2.01B | 1.81B | 1.72B | 1.69B | 1.57B | 1.51B | 1.13B | 889.80M | 830.90M | 795.10M | 720.80M | 656.60M | 572.00M | 524.80M | 552.60M | 84.60M | 54.50M | 29.40M | 18.60M | 16.20M | 12.70M | 10.30M |
| Cost of Revenue | 1.88B | 1.80B | 1.89B | 1.69B | 1.86B | 1.92B | 1.80B | 1.74B | 1.16B | 1.32B | 1.37B | 1.37B | 1.26B | 1.09B | 1.05B | 1.04B | 969.05M | 881.49M | 846.12M | 847.71M | 797.72M | 780.84M | 559.42M | 384.84M | 359.30M | 341.20M | 319.60M | 303.80M | 269.70M | 247.00M | 274.00M | 52.30M | 33.70M | 18.00M | 11.50M | 9.90M | 8.00M | 7.00M |
| Gross Profit | 2.09B | 2.13B | 2.36B | 1.66B | 2.17B | 2.07B | 2.19B | 2.00B | 1.52B | 1.60B | 1.58B | 1.56B | 1.27B | 1.13B | 1.11B | 1.15B | 1.04B | 929.01M | 869.02M | 846.52M | 773.20M | 732.90M | 569.67M | 504.95M | 471.60M | 453.90M | 401.20M | 352.80M | 302.30M | 277.80M | 278.60M | 32.30M | 20.80M | 11.40M | 7.10M | 6.30M | 4.70M | 3.30M |
| Gross Profit Ratio | 52.61% | 54.23% | 55.54% | 49.58% | 53.74% | 51.87% | 54.80% | 53.42% | 56.73% | 54.74% | 53.46% | 53.15% | 50.18% | 50.88% | 51.45% | 52.51% | 51.78% | 51.31% | 50.67% | 49.96% | 49.22% | 48.42% | 50.45% | 56.75% | 56.76% | 57.09% | 55.66% | 53.73% | 52.85% | 52.93% | 50.42% | 38.18% | 38.17% | 38.78% | 38.17% | 38.89% | 37.01% | 32.04% |
| Research & Development | 184.00M | 174.00M | 171.00M | 115.00M | 131.30M | 160.50M | 151.70M | 128.50M | 74.90M | 80.80M | 85.10M | 85.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.62B | 1.60B | 1.55B | 0.00 | 0.00 | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 675.37M | 606.41M | 563.34M | 544.26M | 501.52M | 479.13M | 386.24M | 299.73M | 282.40M | 275.10M | 236.30M | 205.20M | 180.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | -7.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.62B | 1.59B | 1.55B | 1.44B | 1.72B | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 675.37M | 606.41M | 563.34M | 544.26M | 501.52M | 479.13M | 386.24M | 299.73M | 282.40M | 275.10M | 236.30M | 205.20M | 180.10M | 160.30M | 180.00M | 16.70M | 10.50M | 5.50M | 3.90M | 3.40M | 2.90M | 2.30M |
| Other Expenses | 374.00M | 1.29B | 18.00M | 271.00M | 115.00M | 1.34B | 2.07B | 44.10M | 81.20M | 11.10M | 13.40M | -490.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.43M | 0.00 | 0.00 | 0.00 | 0.00 | 5.07M | 41.36M | 39.60M | 37.50M | 32.40M | 28.10M | 21.50M | 20.00M | 19.80M | 4.20M | 3.00M | 2.40M | 1.20M | 500.00K | 500.00K | 400.00K |
| Operating Expenses | 2.18B | 1.76B | 1.72B | 1.44B | 1.72B | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 680.54M | 602.98M | 563.34M | 544.26M | 501.52M | 479.13M | 391.31M | 341.09M | 322.00M | 312.60M | 268.70M | 233.30M | 201.60M | 180.30M | 199.80M | 19.70M | 12.90M | 6.70M | 4.40M | 3.90M | 3.30M | 2.70M |
| Cost & Expenses | 4.05B | 3.56B | 3.61B | 3.12B | 3.59B | 3.64B | 3.48B | 3.27B | 2.23B | 2.47B | 2.52B | 2.52B | 2.20B | 1.83B | 1.77B | 1.78B | 1.65B | 1.48B | 1.41B | 1.39B | 1.30B | 1.26B | 950.73M | 725.94M | 681.30M | 653.80M | 588.30M | 537.10M | 471.30M | 427.30M | 473.80M | 72.00M | 46.60M | 24.70M | 15.90M | 13.80M | 11.30M | 9.70M |
| Interest Income | 0.00 | 60.00M | 55.00M | 1.00M | 2.40M | 2.10M | 2.40M | 2.00M | 2.20M | 5.59M | 8.12M | 8.76M | 9.46M | 4.25M | 5.03M | 17.09M | 26.43M | 12.48M | 9.01M | 5.47M | 1.87M | 0.00 | 0.00 | 862.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 81.00M | 60.00M | 55.00M | 48.00M | 29.40M | 37.30M | 38.30M | 35.90M | 55.90M | 46.91M | 49.63M | 56.85M | 44.62M | 25.09M | 17.83M | 32.53M | 11.98M | 10.80M | 17.77M | 25.10M | 26.08M | 38.18M | 0.00 | 10.15M | 8.50M | 157.10M | 8.10M | 6.00M | 12.20M | 0.00 | 39.20M | 3.80M | 2.80M | 800.00K | 0.00 | 200.00K | 400.00K | 400.00K |
| Depreciation & Amortization | 343.00M | 328.00M | 346.00M | 334.00M | 322.80M | 330.80M | 316.40M | 271.70M | 122.90M | 129.08M | 127.90M | 129.20M | 85.04M | 66.34M | 65.18M | 56.93M | 50.29M | 47.43M | 50.56M | 49.30M | 45.66M | 43.86M | 54.33M | 41.36M | 39.60M | 37.50M | 32.40M | 28.10M | 21.50M | 20.00M | 19.80M | 3.00M | 2.40M | 1.20M | 500.00K | 500.00K | 400.00K | 400.00K |
| EBITDA | 232.00M | -677.00M | 972.00M | 336.00M | 706.60M | -585.30M | -1.25B | 770.50M | 579.30M | 575.25M | 544.88M | 513.34M | 378.71M | 440.00M | 437.28M | 444.33M | 432.26M | 373.21M | 139.00M | 348.77M | 317.34M | 297.63M | 232.70M | 205.22M | 189.20M | 178.70M | 164.90M | 147.60M | 122.20M | 117.50M | 98.60M | 31.60M | 15.60M | 10.30M | 5.90M | 3.20M | 2.90M | 1.80M |
| EBITDA Ratio | 5.85% | 16.17% | 23.57% | 23.64% | 20.97% | 49.83% | 65.43% | 20.63% | 18.87% | 16.01% | 15.11% | 14.80% | 13.26% | 18.11% | 17.97% | 22.19% | 20.92% | 21.14% | 33.94% | 21.25% | 19.96% | 20.02% | 18.64% | 23.38% | 22.41% | 31.40% | 22.56% | 22.08% | 21.64% | 21.95% | 18.24% | 18.79% | 18.72% | 20.07% | 16.67% | 17.90% | 14.17% | 9.71% |
| Operating Income | -85.00M | 306.00M | 622.00M | 456.00M | 522.30M | -958.10M | -1.59B | 454.70M | 375.20M | 445.60M | 419.17M | 381.94M | 300.73M | 380.27M | 381.19M | 380.42M | 354.89M | 314.79M | 72.92M | 295.13M | 267.98M | 256.50M | 178.36M | 163.86M | 149.60M | 141.30M | 132.50M | 119.50M | 100.70M | 97.50M | 78.80M | 12.60M | 7.90M | 4.70M | 2.70M | 2.40M | 1.40M | 600.00K |
| Operating Income Ratio | -2.14% | 7.80% | 14.63% | 13.64% | 12.96% | -24.03% | -39.70% | 12.14% | 14.03% | 15.25% | 14.21% | 13.04% | 11.85% | 17.12% | 17.65% | 17.34% | 17.66% | 17.39% | 4.25% | 17.42% | 17.06% | 16.94% | 15.80% | 18.42% | 18.00% | 17.77% | 18.38% | 18.20% | 17.60% | 18.58% | 14.26% | 14.89% | 14.50% | 15.99% | 14.52% | 14.81% | 11.02% | 5.83% |
| Total Other Income/Expenses | -90.00M | -118.00M | -63.00M | -57.00M | -7.60M | -400.00K | -41.20M | -13.80M | -45.50M | -41.23M | -49.87M | -51.26M | -44.62M | -22.62M | -17.83M | -24.95M | 3.24M | 43.00K | -234.64M | -20.98M | -16.79M | -35.52M | 6.76M | -12.06M | -11.50M | -86.10M | -10.40M | -8.60M | -10.60M | -5.90M | -23.00M | -2.30M | -3.50M | -2.90M | -800.00K | 300.00K | -200.00K | -300.00K |
| Income Before Tax | -175.00M | -1.06B | 559.00M | -60.00M | 345.40M | -958.40M | -1.63B | 440.90M | 329.70M | 404.37M | 369.34M | 330.68M | 256.11M | 357.66M | 363.36M | 355.47M | 358.14M | 314.84M | 71.04M | 274.16M | 251.20M | 220.99M | 185.13M | 151.80M | 138.10M | 55.10M | 122.10M | 110.90M | 90.10M | 91.60M | 55.80M | 9.10M | 5.00M | 3.90M | 2.70M | 2.20M | 1.10M | 0.00 |
| Income Before Tax Ratio | -4.41% | -26.90% | 13.15% | -1.80% | 8.57% | -24.04% | -40.73% | 11.77% | 12.33% | 13.84% | 12.52% | 11.29% | 10.09% | 16.10% | 16.82% | 16.20% | 17.82% | 17.39% | 4.14% | 16.18% | 15.99% | 14.60% | 16.40% | 17.06% | 16.62% | 6.93% | 16.94% | 16.89% | 15.75% | 17.45% | 10.10% | 10.76% | 9.17% | 13.27% | 14.52% | 13.58% | 8.66% | 0.00% |
| Income Tax Expense | -43.00M | -105.00M | 138.00M | 23.00M | 82.30M | 52.50M | -53.20M | 9.50M | 77.00M | 81.12M | 52.15M | 8.92M | -11.02M | 89.23M | 88.94M | 71.60M | 98.48M | 91.12M | 25.63M | 63.87M | 81.34M | 73.03M | 63.63M | 50.78M | 48.20M | 20.30M | 47.50M | 43.70M | 36.10M | 37.50M | 27.70M | 3.80M | 2.10M | 1.50M | 1.00M | 900.00K | 300.00K | 500.00K |
| Net Income | -132.00M | -950.00M | 411.00M | -83.00M | 262.90M | -1.01B | -1.57B | 429.90M | 251.20M | 322.85M | 313.19M | 314.21M | 244.52M | 265.71M | 274.26M | 283.87M | 259.65M | 223.72M | 45.41M | 253.17M | 174.18M | 147.95M | 121.50M | 101.02M | 89.90M | 34.80M | 74.60M | 67.20M | 54.00M | 62.00M | 14.10M | 5.30M | 2.90M | 2.40M | 1.70M | 1.30M | 800.00K | 100.00K |
| Net Income Ratio | -3.33% | -24.22% | 9.67% | -2.48% | 6.52% | -25.36% | -39.39% | 11.48% | 9.39% | 11.05% | 10.61% | 10.73% | 9.64% | 11.96% | 12.70% | 12.94% | 12.92% | 12.36% | 2.65% | 14.94% | 11.09% | 9.77% | 10.76% | 11.35% | 10.82% | 4.38% | 10.35% | 10.23% | 9.44% | 11.81% | 2.55% | 6.26% | 5.32% | 8.16% | 9.14% | 8.02% | 6.30% | 0.97% |
| EPS | -0.62 | -4.41 | 1.88 | -0.38 | 1.18 | -4.51 | -6.86 | 1.97 | 1.79 | 2.28 | 2.20 | 2.22 | 1.73 | 1.85 | 1.85 | 1.90 | 1.71 | 1.44 | 0.29 | 1.58 | 1.11 | 0.95 | 0.78 | 0.65 | 0.57 | 0.22 | 0.46 | 0.42 | 0.33 | 0.37 | 0.09 | 0.10 | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.00 |
| EPS Diluted | -0.62 | -4.41 | 1.87 | -0.38 | 1.17 | -4.51 | -6.86 | 1.94 | 1.76 | 2.24 | 2.16 | 2.18 | 1.70 | 1.82 | 1.83 | 1.87 | 1.68 | 1.41 | 0.28 | 1.55 | 1.09 | 0.93 | 0.77 | 0.65 | 0.56 | 0.22 | 0.46 | 0.42 | 0.33 | 0.37 | 0.09 | 0.10 | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.00 |
| Weighted Avg Shares Out | 212.00M | 215.50M | 218.40M | 219.20M | 223.10M | 224.17M | 229.29M | 218.00M | 140.00M | 141.70M | 142.70M | 141.85M | 141.39M | 143.98M | 148.32M | 149.07M | 151.71M | 155.23M | 159.19M | 160.77M | 157.65M | 156.36M | 155.34M | 155.57M | 158.26M | 159.99M | 161.81M | 161.52M | 162.07M | 165.99M | 151.00M | 52.97M | 43.48M | 34.27M | 33.98M | 29.99M | 34.27M | 29.99M |
| Weighted Avg Shares Out (Dil) | 212.00M | 215.50M | 220.20M | 219.20M | 224.40M | 224.30M | 229.40M | 221.60M | 142.50M | 144.20M | 145.00M | 143.95M | 143.55M | 145.99M | 150.10M | 151.68M | 154.72M | 158.27M | 162.02M | 164.03M | 161.29M | 159.99M | 157.95M | 157.12M | 158.73M | 160.79M | 162.69M | 161.52M | 162.19M | 165.99M | 156.59M | 52.97M | 43.48M | 34.27M | 33.98M | 29.99M | 34.27M | 29.99M |
XRAY LEGAL UPDATE: A Lawsuit has been Filed Against Dentsply Sirona Inc. for Securities Fraud - Contact BFA Law before Court Deadline (NASDAQ:XRAY)
NEW YORK, Nov. 30, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Dentsply Sirona Inc. (NASDAQ: XRAY) and certain of the company's senior executives for potential violations...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XRAY
NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between...
XRAY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Dentsply Sirona Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / November 29, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY)...
XRAY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Dentsply Sirona Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising --Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY)...
XRAY INVESTOR ALERT: Dentsply Sirona Inc. Investors that Lost Money are Reminded of January 27 Class Action Deadline – Contact BFA Law
NEW YORK, NY / ACCESSWIRE / November 28, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Dentsply Sirona Inc. (NASDAQ:XRAY) and certain of the company's senior executives for potential...
XRAY Investors Have Opportunity to Lead Dentsply Sirona Inc. Securities Fraud Lawsuit
NEW YORK , Nov. 28, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between December 1,...
XRAY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Dentsply Sirona Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / November 28, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY)...
Rosen Law Firm Urges Dentsply Sirona Inc. (NASDAQ: XRAY) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between December 1, 2022 and November 6,...
XRAY INVESTOR REPORT: BFA Law Alerts Dentsply Sirona Inc. Investors that a Class Action Lawsuit was Filed Against the Company for Fraud and Urges You to Contact the Firm
NEW YORK, NY / ACCESSWIRE / November 27, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Dentsply Sirona Inc. (NASDAQ:XRAY) and certain of the company's senior executives for potential...
DENTSPLY BREAKING NEWS: BFA Law Announces that Dentsply Sirona Inc. has been Sued for Securities Fraud – Investors with Losses Urged to Contact the Firm (NASDAQ:XRAY)
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Dentsply Sirona Inc. (NASDAQ: XRAY) and certain of the company's senior executives for potential violations...
Source: https://incomestatements.info
Category: Stock Reports